Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day

Conclusions
The Idylla platform is an interesting ancillary first-line fast and fully automated tool to detect EGFR and KRAS mutations in NSCLC samples allowing rapid treatment choices in patients with acute deterioration.

Source: Journal of Clinical Pathology - May 22, 2017 Category: Pathology Authors: Lambros, L., Caumont, C., Guibourg, B., Barel, F., Quintin-Roue, I., Marcorelles, P., Merlio, J.-P., Uguen, A. Tags: Short report Source Type: research